title: Radiation recall dermatitis after docetaxel administration: absolute indication to replace the drug?
authors.forename: F
authors.initials: F
authors.lastname: Borgia
authors.forename: C
authors.initials: C
authors.lastname: Guarneri
authors.forename: F
authors.initials: F
authors.lastname: Guarneri
authors.forename: M
authors.initials: M
authors.lastname: Vaccaro
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D003131:Combined Modality Therapy; D000075202:Contraindications; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008875:Middle Aged; D011838:Radiation-Sensitizing Agents / Q000009:adverse effects*; D011855:Radiodermatitis / Q000209:etiology*; D043823:Taxoids / Q000009:adverse effects*
chemical_list: D011838:Radiation-Sensitizing Agents; D043823:Taxoids; D000077143:Docetaxel